Tau oligomers can occur in human brains within days of a single traumatic brain injury
Vuono, R.; Bhorla, S. K.; Steponenaite, A.; Allinson, K.; Coleman, M.
Show abstract
Traumatic brain injury (TBI) is a major risk factor for Alzheimers disease (AD), yet the early molecular events linking the two remain unclear. Neurofibrillary tangles (NFTs), a hallmark of AD, are observed in individuals with a history of single or repetitive head injury. Animal studies show that tau oligomers, the toxic species preceding the NFTs, appear shortly after TBI, but corresponding human data are lacking. Here, we investigated tau changes in the brains of individuals who died shortly after TBI compared to those surviving long-term. We report abnormal tau oligomers in the brain of short-term survivors whereas NFTs were the main feature in long-term survivors. These findings support a model where TBI triggers early tau oligomers formation that spread through a prion-like mechanism, seeding tau pathology and contributing to late-onset AD. The novel identification of tau oligomers in acute TBI reveals potential early disease mechanisms and therapeutic targets for AD prevention. Importance statementBy revealing a potential early disease mechanism of Alzheimers disease (AD), this study represents a major breakthrough in our understanding, treatment and prevention of the disease. To our knowledge, this is the first report of tau oligomers in the brain of individuals suffering acute Traumatic Brain Injury (TBI). This is an important finding considering that TBI is a major risk factor of AD and tau oligomers are thought to be the most toxic species preceding tau pathology, a characteristic signature of AD. The identification of these early tau-related events after TBI provides insight into potential early AD mechanisms and offers a unique opportunity for early therapeutic intervention and prevention.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimers disease 96%
- TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus 95%
- Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer s disease pathogenesis 95%
Similar papers in this journal
- Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau 96%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 95%
- Neuronal Tau Pathology Worsens Late Phase White Matter Degeneration After Traumatic Brain Injury in Transgenic Mice 95%
Similar papers in this journal
Similar papers in this journal
- Knockout of TSPO delays and reduces amyloid, Tau, astrocytosis and behavioral dysfunctions in Alzheimer's disease. 95%
- Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced tau mislocalization and synaptotoxicity 94%
- Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.